Dramatic change for traditional immunoassay technology as new market model creates enormous opportunity…..
The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.
Reviews
There are no reviews yet.